Corin’s Cormet 2000 Hip Resurfacing System Is “Approvable With Conditions”
This article was originally published in The Gray Sheet
Executive Summary
Corin's Cormet 2000 hip resurfacing system requires a postmarket study to address long-term safety concerns, FDA's Orthopedic and Rehabilitation Devices Panel recommended Feb. 22
You may also be interested in...
Stryker Cormet Hip Resurfacing Gains FDA Approval, Will Debut By September
Stryker will begin training surgeons on Corin Group's Cormet hip resurfacing system within the next three months in anticipation of a U.S. launch by the end of September, the firms say
Stryker Cormet Hip Resurfacing Gains FDA Approval, Will Debut By September
Stryker will begin training surgeons on Corin Group's Cormet hip resurfacing system within the next three months in anticipation of a U.S. launch by the end of September, the firms say
Smith & Nephew Unveils CEO Succession Plan, Cost-Cutting Measures
Incoming Smith & Nephew CEO David Illingworth's top priority will be a cost-cutting strategy to improve profit margins by an average of 1% annually through 2010